Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.

Lambert, Mélanie

Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension. [electronic resource] - Cardiovascular research 05 2018 - 880-893 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1755-3245

10.1093/cvr/cvy016 doi


Action Potentials
Adolescent
Adult
Animals
Case-Control Studies
Disease Models, Animal
Down-Regulation
Female
Humans
Hypertension, Pulmonary--complications
Hypertrophy, Right Ventricular--etiology
Male
Middle Aged
Myocytes, Cardiac--drug effects
Nerve Tissue Proteins--antagonists & inhibitors
Potassium Channel Blockers--pharmacology
Potassium Channels, Tandem Pore Domain--antagonists & inhibitors
Rats
Signal Transduction
Sulfonamides--pharmacology
Time Factors
Ventricular Dysfunction, Right--etiology
Ventricular Function, Right--drug effects
Ventricular Remodeling--drug effects
ortho-Aminobenzoates--pharmacology